United States · FDA National Drug Code directory
Cetirizine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-093_26beeb96-f0b4-4e99-ba9d-3b27c67659dc
- Product NDC
- 71205-093
- Form
- TABLET
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091001
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET in 1 BOTTLE (71205-093-15) · 71205-093-15
- 30 TABLET in 1 BOTTLE (71205-093-30) · 71205-093-30
- 60 TABLET in 1 BOTTLE (71205-093-60) · 71205-093-60
- 90 TABLET in 1 BOTTLE (71205-093-90) · 71205-093-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →